Comparison of the predicted protein structure of human and mouse sialoadhesin
Domain . | Length HSn (mSn) . | Identity, % . | Similarity, % . |
---|---|---|---|
Leader | 19 (19) | 57.9 | 57.9 |
1 (V) | 117 (117) | 78.6 | 89.7 |
2 (C2) | 99 (100) | 60.6 | 71.7 |
3 (C2) | 89 (89) | 67.4 | 82.0 |
4 (C2) | 85 (85) | 74.1 | 87.1 |
5 (C2) | 100 (100) | 76.0 | 86.0 |
6 (C2) | 86 (86) | 79.1 | 84.9 |
7 (C2) | 112 (107) | 65.2 | 77.7 |
8 (C2) | 86 (86) | 76.7 | 86.0 |
9 (C2) | 101 (101) | 79.2 | 89.1 |
10 (C2) | 87 (86) | 75.8 | 87.4 |
11 (C2) | 104 (104) | 69.2 | 77.9 |
12 (C2) | 84 (84) | 72.6 | 79.8 |
13 (C2) | 90 (90) | 78.9 | 87.8 |
14 (C2) | 84 (84) | 70.2 | 79.8 |
15 (C2) | 100 (102) | 76.0 | 82.0 |
16 (C2) | 87 (87) | 73.6 | 79.3 |
17 (C2) | 111 (111) | 73.0 | 83.8 |
TD | 24 (21) | 71.4 | 71.4 |
CT | 44 (35) | 29.8 | 40.4 |
Total | 1709 (1694) | 71.9 | 81.5 |
Domain . | Length HSn (mSn) . | Identity, % . | Similarity, % . |
---|---|---|---|
Leader | 19 (19) | 57.9 | 57.9 |
1 (V) | 117 (117) | 78.6 | 89.7 |
2 (C2) | 99 (100) | 60.6 | 71.7 |
3 (C2) | 89 (89) | 67.4 | 82.0 |
4 (C2) | 85 (85) | 74.1 | 87.1 |
5 (C2) | 100 (100) | 76.0 | 86.0 |
6 (C2) | 86 (86) | 79.1 | 84.9 |
7 (C2) | 112 (107) | 65.2 | 77.7 |
8 (C2) | 86 (86) | 76.7 | 86.0 |
9 (C2) | 101 (101) | 79.2 | 89.1 |
10 (C2) | 87 (86) | 75.8 | 87.4 |
11 (C2) | 104 (104) | 69.2 | 77.9 |
12 (C2) | 84 (84) | 72.6 | 79.8 |
13 (C2) | 90 (90) | 78.9 | 87.8 |
14 (C2) | 84 (84) | 70.2 | 79.8 |
15 (C2) | 100 (102) | 76.0 | 82.0 |
16 (C2) | 87 (87) | 73.6 | 79.3 |
17 (C2) | 111 (111) | 73.0 | 83.8 |
TD | 24 (21) | 71.4 | 71.4 |
CT | 44 (35) | 29.8 | 40.4 |
Total | 1709 (1694) | 71.9 | 81.5 |
HSn indicates human sialoadhesin; mSn, mouse sialoadhesin; V, V-set Ig-like domain; C2, C2-set Ig-like domain; TD, transmembrane domain; CT, cytoplasmic tail.